Online inquiry

IVTScrip™ mRNA-Human AMPH, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK16060MR)

This product GTTS-WK16060MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AMPH protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001635.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 273
UniProt ID P49418
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AMPH, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK16060MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK14998MR IVTScrip™ mRNA-Human APBB1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APBB1
GTTS-WK23516MR IVTScrip™ mRNA-Human ARHGEF3, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF3
GTTS-WK20126MR IVTScrip™ mRNA-Human AHSA1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AHSA1
GTTS-WK19590MR IVTScrip™ mRNA-Human Albumin, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Albumin
GTTS-WK28593MR IVTScrip™ mRNA-Human ARHGAP29, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP29
GTTS-WK25937MR IVTScrip™ mRNA-Human ARL16, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARL16
GTTS-WK0543MR IVTScrip™ mRNA-Human CD133, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CD133
GTTS-WK9877MR IVTScrip™ mRNA-Human AES, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AES
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW